BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

23 related articles for article (PubMed ID: 20956388)

  • 1. Diagnostic value of tumor markers in identifying favorable or unfavorable subsets in patients with cancer of unknown primary: a retrospective study.
    Takamizawa S; Shimoi T; Yoshida M; Tokura M; Yazaki S; Mizoguchi C; Saito A; Kita S; Yamamoto K; Kojima Y; Sumiyoshi-Okuma H; Nishikawa T; Noguchi E; Sudo K; Yonemori K
    BMC Cancer; 2022 Apr; 22(1):412. PubMed ID: 35421961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural Characterization of Cuta- and Tusavirus: Insight into Protoparvoviruses Capsid Morphology.
    Mietzsch M; McKenna R; Väisänen E; Yu JC; Ilyas M; Hull JA; Kurian J; Smith JK; Chipman P; Lasanajak Y; Smith D; Söderlund-Venermo M; Agbandje-McKenna M
    Viruses; 2020 Jun; 12(6):. PubMed ID: 32560452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The physiological and pathological roles and applications of sialyl Lewis x, a common carbohydrate ligand of the three selectins.
    Jin F; Wang F
    Glycoconj J; 2020 Apr; 37(2):277-291. PubMed ID: 32062824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated serum levels of sialyl Lewis X (sLe
    Cohen EN; Fouad TM; Lee BN; Arun BK; Liu D; Tin S; Gutierrez Barrera AM; Miura T; Kiyokawa I; Yamashita J; Alvarez RH; Valero V; Woodward WA; Shen Y; Ueno NT; Cristofanilli M; Reuben JM
    Breast Cancer Res Treat; 2019 Aug; 176(3):545-556. PubMed ID: 31054033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selectin Ligands Sialyl-Lewis a and Sialyl-Lewis x in Gastrointestinal Cancers.
    Trinchera M; Aronica A; Dall'Olio F
    Biology (Basel); 2017 Feb; 6(1):. PubMed ID: 28241499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of α-L-fucosidase 1 expression confers inferior survival for triple-negative breast cancer patients by modulating the glycosylation status of the tumor cell surface.
    Cheng TC; Tu SH; Chen LC; Chen MY; Chen WY; Lin YK; Ho CT; Lin SY; Wu CH; Ho YS
    Oncotarget; 2015 Aug; 6(25):21283-300. PubMed ID: 26204487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The architecture and biological function of dual antibody-coated dendrimers: enhanced control of circulating tumor cells and their hetero-adhesion to endothelial cells for metastasis prevention.
    Xie J; Zhao R; Gu S; Dong H; Wang J; Lu Y; Sinko PJ; Yu T; Xie F; Wang L; Shao J; Jia L
    Theranostics; 2014; 4(12):1250-63. PubMed ID: 25285173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of the metastatic cell phenotype by sialylated glycans.
    Schultz MJ; Swindall AF; Bellis SL
    Cancer Metastasis Rev; 2012 Dec; 31(3-4):501-18. PubMed ID: 22699311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Galectin-1-binding glycoforms of haptoglobin with altered intracellular trafficking, and increase in metastatic breast cancer patients.
    Carlsson MC; Cederfur C; Schaar V; Balog CI; Lepur A; Touret F; Salomonsson E; Deelder AM; Fernö M; Olsson H; Wuhrer M; Leffler H
    PLoS One; 2011; 6(10):e26560. PubMed ID: 22028908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific detection of sialyl Lewis X determinant carried on the mucin GlcNAcbeta1-->6GalNAcalpha core structure as a tumor-associated antigen.
    Kumamoto K; Mitsuoka C; Izawa M; Kimura N; Otsubo N; Ishida H; Kiso M; Yamada T; Hirohashi S; Kannagi R
    Biochem Biophys Res Commun; 1998 Jun; 247(2):514-7. PubMed ID: 9642161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of ABH/Lewis-related antigens as prognostic factors in patients with breast cancer.
    Nakagoe T; Fukushima K; Itoyanagi N; Ikuta Y; Oka T; Nagayasu T; Ayabe H; Hara S; Ishikawa H; Minami H
    J Cancer Res Clin Oncol; 2002 May; 128(5):257-64. PubMed ID: 12029441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CSLEX (Sialyl Lewis X) is a useful tumor marker for monitoring of breast cancer patients.
    Fujita T; Murayama K; Hanamura T; Okada T; Ito T; Harada M; Komatsu A; Koyama H; Kanai T; Maeno K; Mochizuki Y; Hama Y; Ito K; Amano J; Fujimori M
    Jpn J Clin Oncol; 2011 Mar; 41(3):394-9. PubMed ID: 20956388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined measurement of serum sialyl Lewis X with serum CA15-3 in breast cancer patients.
    Kurebayashi J; Nomura T; Hirono M; Okubo S; Udagawa K; Shiiki S; Ikeda M; Nakashima K; Tanaka K; Sonoo H
    Jpn J Clin Oncol; 2006 Mar; 36(3):150-3. PubMed ID: 16520359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive value of preoperative serum sialyl Lewis X-i antigen levels in non-small cell lung cancer.
    Satoh H; Ishikawa H; Yamashita YT; Takahashi H; Ishikawa S; Kamma H; Ohtsuka M; Hasegawa S
    Anticancer Res; 1998; 18(4B):2865-8. PubMed ID: 9713476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum sialyl lewis X-i antigen levels in non-small cell lung cancer: correlation with distant metastasis and survival.
    Satoh H; Ishikawa H; Kamma H; Yamashita YT; Takahashi H; Ohtsuka M; Hasegawa S
    Clin Cancer Res; 1997 Apr; 3(4):495-9. PubMed ID: 9815711
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.